FDA Approves Herpes Drug for Some Patients

“The US FDA on Friday [10/09/26] approved Japan's Asahi Kasei's drug for persistent herpes simplex virus ​sores in certain patients with weakened immune systems ‌who have not responded to available antiviral treatments… Pritelivir blocks proteins ​the herpes virus needs to copy its genetic ⁠material, stopping it from multiplying and allowing the ​drug to work against […] The post FDA Approves Herpes Drug for Some Patients appeared first on Human Progress.